A Reversal on Sequencing? Proposed Legislation Would Allow Patenting of Naturally Occurring Genes
FDA Law Blog
OCTOBER 24, 2024
Mutations in these genes vastly increase the risk of breast and ovarian cancer in women who carry them, and the isolation of BRCA 1/2 allowed clinical laboratories to develop tests enabling the identification of women at heightened risk. Cook-Deegan et al.
Let's personalize your content